Rosiglitazone treatment decreases a myloid formation following transplantation of human-islet amyloid polypeptide (hIAPP) transgenic islets
conference contribution
posted on 2008-06-01, 00:00authored byJayalakshmi Udayasankar, Rebecca L Hull, Sakeneh Zraika, Kathryn Aston-MourneyKathryn Aston-Mourney, Shoba L Subramanian, Gerald J Taborsky, Steven E Kahn
Rosiglitazone treatment decreases a myloid formation following transplantation of human-islet amyloid polypeptide (hIAPP) transgenic islets